Clinical Trial Update: A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical trial evaluating Bexmarilimab in combination with doxorubicin for metastatic soft tissue sarcoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Bexmarilimab (Bexmarilimab)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: MedSIR | Conditions: Sarcoma of Soft Tissue | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING